Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients.
Saved in:
| Title: | Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients. |
|---|---|
| Authors: | Mohan MP; Boston Medical Center, Boston University School of Medicine, Boston, MA, 02118, USA., Pili R; Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY, 14203, USA., Epstein JB; City of Hope Comprehensive Cancer Center, Duarte CA and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical System, Los Angeles, CA, USA., Rudin L; Department of Medicine, University at Buffalo, Buffalo, NY, 14203, USA., Eichhorn S; Boston Medical Center, Boston University School of Medicine, Boston, MA, 02118, USA., Satheeshkumar PS; Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY, 14203, USA. spoolakk@buffalo.edu. |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Dec 12; Vol. 33 (1), pp. 22. Date of Electronic Publication: 2024 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1433-7339 |
|---|---|
| DOI: | 10.1007/s00520-024-09071-4 |
